Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma

Chao Zhang1 Department of Thoracic Surgery, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang, China, [email protected]

Haitang Yang2 Division of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland;3 Department for BioMedical Research, University of Bern, Bern, Switzerland;4 Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland

Baoping Lang1 Department of Thoracic Surgery, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang, China, [email protected]

Xiangdong Yu1 Department of Thoracic Surgery, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang, China, [email protected]

Peng Xiao1 Department of Thoracic Surgery, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang, China, [email protected]

Dian Zhang1 Department of Thoracic Surgery, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang, China, [email protected]

Liwen Fan5 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China

Xiao Zhang1 Department of Thoracic Surgery, The Affiliated Luoyang Central Hospital of Zhengzhou University, Luoyang, China, [email protected]Correspondence[email protected]

show all

Pages 2401-2407 | Published online: 02 Aug 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

CookeDTNguyenDVYangYSurvival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomyAnn Thorac Surg201090394394820732522
PubMed Web of Science ®Google Scholar
GawrychowskiJBrulińskiKMalinowskiEPaplaBPrognosis and survival after radical resection of primary adenosquamous lung carcinomaEur J Cardiothorac Surg200527468669215784375
PubMed Web of Science ®Google Scholar
TravisWDBrambillaEBurkeAPMarxANicholsonAGWHO classification of tumours of the lung, pleura, thymus and heartLyonInternational Agency for Research on Cancer2015
Google Scholar
MaedaHMatsumuraAKawabataTAdenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma casesEur J Cardiothorac Surg201241235736121737295
PubMed Web of Science ®Google Scholar
FilossoPLRuffiniEAsioliSAdenosquamous lung carcinomas: a histologic subtype with poor prognosisLung Cancer2011741252921371773
PubMed Web of Science ®Google Scholar
BastideKUgolinNLevaloisCBernaudinJFChevillardSAre adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?Lung Cancer20106811920004040
PubMed Web of Science ®Google Scholar
ZhaoHYangHYaoFImproved survival associated with a balanced structure between adenomatous and squamous components in patients with adenosquamous carcinoma of the lungEur J Surg Oncol201642111699170627365198
PubMed Web of Science ®Google Scholar
SheltonDARanaDNHolbrookMTaylorPBaileySAdenosquamous carcinoma of the lung diagnosed by cytology?: a diagnostic dilemmaDiagn Cytopathol201240983083321416646
PubMed Web of Science ®Google Scholar
ChenJGaoYDCaoYYangJLuoGWSurgical specimen histology revealed inadequacy of conventional transbronchial needle aspiration sample in the diagnosis of adenosquamous lung carcinomaJ Thorac Dis20157468068625973234
PubMed Web of Science ®Google Scholar
ZhangCYangHZhaoHClinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experienceJ Thorac Dis20179115115828203418
PubMed Web of Science ®Google Scholar
ScagliottiGVParikhPvon PawelJPhase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerJ Clin Oncol200826213543355118506025
PubMed Web of Science ®Google Scholar
ScagliottiGHannaNFossellaFThe differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studiesOncologist200914325326319221167
PubMed Web of Science ®Google Scholar
JohnsonDHFehrenbacherLNovotnyWFRandomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerJ Clin Oncol200422112184219115169807
PubMed Web of Science ®Google Scholar
JiaXLChenGEGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lungLung Cancer201174339640021592614
PubMed Web of Science ®Google Scholar
SongZLinBShaoLZhangYTherapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinomaJ Chin Med Assoc201376948148523769878
PubMed Web of Science ®Google Scholar
EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
PubMed Web of Science ®Google Scholar
DragnevKHGehrGMemoliVATafeLJALK-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: a potential challenge to histologic type triaging of NSCLC biopsies for molecular studiesClin Lung Cancer2014153e37e4024524823
PubMed Web of Science ®Google Scholar
JuknaAMontanariGMengoliMCSquamous cell carcinoma “transformation” concurrent with secondary T790M mutation in resistant EGFR-mutated adenocarcinomasJ Thorac Oncol2016114e49e5126746366
PubMed Web of Science ®Google Scholar
LongoLMengoliMCBertoliniFSynchronous occurrence of squamous-cell carcinoma “transformation” and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinomaLung Cancer2017103242628024692
PubMed Web of Science ®Google Scholar
SongXWangZClinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutationsOnco Targets Ther2017103119312228790845
PubMed Web of Science ®Google Scholar
WangRPanYLiCAnalysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomasJ Thorac Oncol20149676076824481316
PubMed Web of Science ®Google Scholar
PowrózekTKrawczykPRamlauREGFR gene mutations in patients with adenosquamous lung carcinomaAsia Pac J Clin Oncol201410434034524575772
PubMed Web of Science ®Google Scholar
MorodomiYOkamotoTTakenoyamaMClinical Significance of Detecting Somatic Gene Mutations in Surgically Resected Adeno-squamous Cell Carcinoma of the Lung in Japanese PatientsAnn Surg Oncol20152282593259825373537
PubMed Web of Science ®Google Scholar
ShiozawaTIshiiGGotoKClinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lungPathol Int2013632778423464964
PubMed Web of Science ®Google Scholar
FanLYangHYaoFClinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resectionOnco Targets Ther20171023924528123305
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date